Clinical Trial Update: Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

Clinical trial update for autologous GPC3 CAR-T cell therapy (CBG166) for advanced hepatocellular carcinoma; Phase 1, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Autologous GPC3 CAR-T Cells (CBG166) (GPC3-targeted CAR-T cell therapy)

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING